- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 23
  num_fold: 3763
  S: 2995
  I: 684
  R: 84
  median_fold: 1.8
  percent: 7.7
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 18
  num_fold: 604
  S: 456
  I: 126
  R: 22
  median_fold: 2.5
  percent: 1.2
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 147
  num_fold: 15644
  S: 11647
  I: 3180
  R: 817
  median_fold: 2.4
  percent: 32.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 33
  num_fold: 1345
  S: 818
  I: 476
  R: 51
  median_fold: 3.6
  percent: 2.7
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 44
  num_fold: 2382
  S: 1540
  I: 729
  R: 113
  median_fold: 4.0
  percent: 4.9
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 5
  num_fold: 116
  S: 83
  I: 26
  R: 7
  median_fold: 4.1
  percent: 0.24
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.32
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.029
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 56
  num_fold: 5248
  S: 3679
  I: 1300
  R: 269
  median_fold: 2.3
  percent: 11.0
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 334
  S: 241
  I: 74
  R: 19
  median_fold: 3.0
  percent: 0.68
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 15
  num_fold: 725
  S: 440
  I: 263
  R: 22
  median_fold: 4.2
  percent: 1.5
  priority: 2
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 7
  num_fold: 700
  S: 270
  I: 177
  R: 253
  median_fold: 8.6
  percent: 1.4
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 31
  S: 30
  I: 1
  R: 0
  median_fold: 1.8
  percent: 0.063
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 28
  num_fold: 1554
  S: 923
  I: 459
  R: 172
  median_fold: 4.2
  percent: 3.2
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 9
  num_fold: 232
  S: 191
  I: 39
  R: 2
  median_fold: 1.6
  percent: 0.47
  priority: 3
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 342
  S: 93
  I: 240
  R: 9
  median_fold: 6.8
  percent: 0.7
  priority: 3
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 459
  S: 224
  I: 114
  R: 121
  median_fold: 5.2
  percent: 0.94
  priority: 6
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 32
  S: 24
  I: 6
  R: 2
  median_fold: 2.8
  percent: 0.065
  priority: 6
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 142
  S: 28
  I: 114
  R: 0
  median_fold: 5.7
  percent: 0.29
  priority: 6
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 81
  S: 70
  I: 11
  R: 0
  median_fold: 1.3
  percent: 0.17
  priority: 7
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 6
  num_fold: 264
  S: 183
  I: 77
  R: 4
  median_fold: 1.9
  percent: 0.54
  priority: 8
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 499
  S: 100
  I: 398
  R: 1
  median_fold: 20.0
  percent: 1.0
  priority: 8
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.97
  priority: 9
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 172
  S: 152
  I: 0
  R: 20
  median_fold: 2.4
  percent: 0.35
  priority: 9
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.27
  priority: 10
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 70
  S: 2
  I: 68
  R: 0
  median_fold: 8.0
  percent: 0.14
  priority: 10
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 12
  num_fold: 1490
  S: 985
  I: 491
  R: 14
  median_fold: 3.9
  percent: 3.0
  priority: 10
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 3
  num_fold: 71
  S: 13
  I: 18
  R: 40
  median_fold: 109.0
  percent: 0.14
  priority: 10
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 758
  S: 348
  I: 410
  R: 0
  median_fold: 5.2
  percent: 1.5
  priority: 10
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 404
  S: 253
  I: 151
  R: 0
  median_fold: 3.6
  percent: 0.82
  priority: 10
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 148
  S: 110
  I: 34
  R: 4
  median_fold: 2.3
  percent: 0.3
  priority: 11
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 64
  S: 40
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.13
  priority: 13
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 6
  num_fold: 459
  S: 311
  I: 106
  R: 42
  median_fold: 2.7
  percent: 0.94
  priority: 14
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 15
  num_fold: 852
  S: 666
  I: 124
  R: 62
  median_fold: 2.4
  percent: 1.7
  priority: 15
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 4
  num_fold: 141
  S: 99
  I: 37
  R: 5
  median_fold: 2.6
  percent: 0.29
  priority: 15
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 306
  S: 196
  I: 109
  R: 1
  median_fold: 3.6
  percent: 0.62
  priority: 15
- vaccine: mRNA-1273 + mRNA-1273.351
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 237
  S: 222
  I: 11
  R: 4
  median_fold: 2.2
  percent: 0.48
  priority: 18
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 13
  S: 0
  I: 10
  R: 3
  median_fold: 15.0
  percent: 0.027
  priority: 25
- vaccine: BNT162b2 or AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 38
  S: 30
  I: 7
  R: 1
  median_fold: 3.2
  percent: 0.077
  priority: 26
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 142
  S: 42
  I: 82
  R: 18
  median_fold: 6.6
  percent: 0.29
  priority: 31
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 138
  S: 39
  I: 95
  R: 4
  median_fold: 5.7
  percent: 0.28
  priority: 34
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 280
  S: 218
  I: 62
  R: 0
  median_fold: 2.8
  percent: 0.57
  priority: 1000
